In addition, iron-regulator expression in AML is associated with an inflammatory milieu, and AML patients with low levels of FPN may have reduced FPN expression due to greater autocrine or paracrine secretion of inflammatory cytokines (such as IL-6) (Vela et al., 2018). Here, SLC40A1 is linked to acute myeloid leukemia.